Hugo, Feona .
HRN: 22-63-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/13/2023
12/19/2023
IVT
300mg
Q6
Acute Tonsillopharyngitis Urti
Waiting Final Action
Indication: Empiric Type of Infection: URTIEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes